Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS)

Clinical trial NCT00795639 · TERMINATED

Trial details

NCT number: NCT00795639
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension Pulmonary Hypertension

Start date: 2008-12-01
Primary completion: 2011-03-01
Enrollment: 183

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.